期刊文献+

阿德福韦酯治疗慢性乙型肝炎患者的临床疗效观察 被引量:10

下载PDF
导出
摘要 目的观察阿德福韦酯对慢性乙型肝炎患者的临床疗效。方法随机选择慢性乙型肝炎患者39例,其中12例为拉米夫定治疗后出现YMDD变异者。治疗48周,检测血清HBV DNA及HBV血清学标志物和ALT。结果治疗48周时,全组血清HBV DNA水平下降到1.3×103copies/ml,HBV DNA转阴率为56.4%,HBeAg转阴率为35.9%,HBeAg/抗-HBe转换率12.8%,ALT复常率为69.2%;YMDD变异组血清HBV DNA水平下降到7.9×103copies/ml,HBV DNA转阴率为50.0%,HBeAg转阴率为25.0%,HBeAg/抗-HBe转换率8.3%,ALT复常率为58.3%;HBV DNA>108copies/ml组,血清HBV DNA水平下降到6.8×103copies/ml,HBV DNA转阴率为0.0%,无HBeAg转阴和抗-HBe血清转换,ALT复常率为50.0%。结论阿德福韦酯是一有效的抗HBV药物。对HBV DNA野生株、拉米夫定耐药变异株均有抑制作用,HBV DNA基线水平低者疗效好,HBV DNA>108copies/ml者,疗效差。
出处 《实用肝脏病杂志》 CAS 2007年第3期180-182,共3页 Journal of Practical Hepatology
  • 相关文献

参考文献6

二级参考文献40

  • 1Liaw YF, Leung NWY, Chang TY, et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology, 2000,119: 172-180. 被引量:1
  • 2Leung NWY, Lai CL, Chang TY, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology, 2001,33: 1527-1532. 被引量:1
  • 3Schiff ER, Lai CL, Hadziyannis S, et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology, 2003,38 : 1419-1427. 被引量:1
  • 4Westland CE, Yang H, Delaney WE, et al. Activity of adefovir dipivoxil against all pattems, of lamivudine-resistant hepatitis B viruses in patients. J Viral Hepatitis, 2005,12: 67-73. 被引量:1
  • 5Peters MG, Harm Hw H, Martin P, et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology, 2004,126:91-101. 被引量:1
  • 6Hadziyannis S,Tassopoulos N,Chang TT,et al.Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B patients in a long-term safety and efficacy study.J Hepatol,2004,40(Suppl 1):17 (Abstract 46). 被引量:1
  • 7Hadziyannis SJ,Papatheodoridis GV.Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.Expert Rev Anti Infect Ther,2004,2:475-483. 被引量:1
  • 8Marcellin P,Chang TT,Lim SG,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.N Engl J Med,2003,348:808-816. 被引量:1
  • 9Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.N Engl J Med,2003,348:800-807. 被引量:1
  • 10Cullen JM,Li DH,Brown C,et al.Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks.Antimicrob Agents Chemother,2001,45:2740-2745. 被引量:1

共引文献483

同被引文献60

引证文献10

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部